• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿莫西林对幽门螺杆菌的杀菌及形态学作用

Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.

作者信息

Berry V, Jennings K, Woodnutt G

机构信息

SmithKline Beecham Pharmaceuticals, Brockham Park, Betchworth, Surrey, England.

出版信息

Antimicrob Agents Chemother. 1995 Aug;39(8):1859-61. doi: 10.1128/AAC.39.8.1859.

DOI:10.1128/AAC.39.8.1859
PMID:7486933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC162840/
Abstract

The growth kinetics of Helicobacter pylori after it has been exposed to amoxicillin have been investigated in conjunction with studies of cell morphology. A potent bactericidal effect was observed at concentrations 10-fold higher than the MIC, but this was accompanied by an increase in the residual numbers of coccoid forms observed. In the presence of 10 micrograms of amoxicillin per ml, these forms could be detected as rapidly as 6 h after exposure to the antibiotic. Although the clinical relevance of coccoid forms remains unknown, such forms should be considered when potential anti-Helicobacter agents are tested in vitro.

摘要

幽门螺杆菌暴露于阿莫西林后的生长动力学已结合细胞形态学研究进行了调查。在浓度比最低抑菌浓度(MIC)高10倍时观察到了强大的杀菌作用,但与此同时,观察到的类球形体残留数量有所增加。在每毫升含10微克阿莫西林的情况下,接触抗生素后6小时就能迅速检测到这些类球形体。尽管类球形体的临床相关性尚不清楚,但在体外测试潜在的抗幽门螺杆菌药物时应考虑到这些形态。

相似文献

1
Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.阿莫西林对幽门螺杆菌的杀菌及形态学作用
Antimicrob Agents Chemother. 1995 Aug;39(8):1859-61. doi: 10.1128/AAC.39.8.1859.
2
Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.罗他霉素对幽门螺杆菌的抑制和杀菌活性及形态学改变
J Chemother. 1996 Dec;8(6):425-31. doi: 10.1179/joc.1996.8.6.425.
3
Overexpression of spoT gene in coccoid forms of clinical Helicobacter pylori isolates.临床幽门螺杆菌分离株球状体中spoT基因的过表达。
Folia Microbiol (Praha). 2018 Jul;63(4):459-465. doi: 10.1007/s12223-017-0557-0. Epub 2018 Jan 11.
4
Amoxicillin for the treatment of Helicobacter pylori infection.
J Gastroenterol. 1996 Nov;31 Suppl 9:44-7.
5
Assessment of cagE and babA mRNA expression during morphological conversion of Helicobacter pylori from spiral to coccoid.评估幽门螺旋杆菌从螺旋形到球形形态转换过程中 cagE 和 babA mRNA 的表达。
Curr Microbiol. 2013 Apr;66(4):406-13. doi: 10.1007/s00284-012-0280-7. Epub 2012 Dec 24.
6
Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent?阿莫西林对幽门螺杆菌的杀菌活性是否具有浓度依赖性?
Antimicrob Agents Chemother. 1996 May;40(5):1327-8. doi: 10.1128/AAC.40.5.1327.
7
In vitro activity of clarithromycin against intracellular Helicobacter pylori.克拉霉素对细胞内幽门螺杆菌的体外活性。
Antimicrob Agents Chemother. 2001 May;45(5):1568-71. doi: 10.1128/AAC.45.5.1568-1571.2001.
8
Helicobacter pylori: cultivability and antibiotic susceptibility of coccoid forms.幽门螺杆菌:球形形态的可培养性及抗生素敏感性
Int J Antimicrob Agents. 2000 Feb;13(4):237-41. doi: 10.1016/s0924-8579(99)00128-4.
9
Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.多种β-内酰胺类抗生素对幽门螺杆菌主要青霉素结合蛋白的竞争作用:抗菌活性及对细菌形态的影响
Antimicrob Agents Chemother. 1999 Nov;43(11):2702-9. doi: 10.1128/AAC.43.11.2702.
10
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.阿莫西林、甲硝唑、水杨酸铋和六种氨基糖苷类药物对幽门螺杆菌的活性。
J Chemother. 1996 Feb;8(1):52-4. doi: 10.1179/joc.1996.8.1.52.

引用本文的文献

1
Targeting Urease: A Promising Adjuvant Strategy for Effective Eradication.靶向脲酶:一种有望实现有效根除的辅助策略。
ACS Omega. 2025 Jul 4;10(27):28643-28669. doi: 10.1021/acsomega.5c02725. eCollection 2025 Jul 15.
2
Targeted nanomedicines for the treatment of infection.用于治疗感染的靶向纳米药物。
Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.
3
Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective.幽门螺杆菌的抗生素耐药性:遗传学和生理学视角
Gut Pathog. 2025 May 23;17(1):35. doi: 10.1186/s13099-025-00704-5.
4
A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori.一项关于沃诺拉赞联合阿莫西林双联方案根除幽门螺杆菌疗效的随机临床研究。
Medicine (Baltimore). 2023 Oct 13;102(41):e35610. doi: 10.1097/MD.0000000000035610.
5
Dormant States Are Affected by Vitamin C.休眠状态受维生素 C 的影响。
Int J Mol Sci. 2023 Mar 17;24(6):5776. doi: 10.3390/ijms24065776.
6
High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of infection: A meta-analysis of randomized controlled trials.高剂量双联疗法与铋剂四联疗法治疗 感染:一项随机对照试验的荟萃分析。
Saudi J Gastroenterol. 2023 Mar-Apr;29(2):88-94. doi: 10.4103/sjg.sjg_532_22.
7
High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis.高剂量双联疗法与铋剂四联疗法治疗幽门螺杆菌感染的系统评价与 Meta 分析。
Turk J Gastroenterol. 2022 Jun;33(6):454-462. doi: 10.5152/tjg.2022.21579.
8
The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Eradication: An Open-Label Random Trial.大剂量质子泵抑制剂诱导治疗在根除双重疗法前的应用:一项开放标签随机试验
J Clin Med. 2021 Sep 24;10(19):4352. doi: 10.3390/jcm10194352.
9
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.幽门螺杆菌感染和抗生素耐药性 - 从生物学到临床意义。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
10
Antibiotics as a Stressing Factor Triggering the Harboring of J99 within ATCC10231.抗生素作为一种应激因素触发了ATCC10231内J99的携带。
Pathogens. 2021 Mar 23;10(3):382. doi: 10.3390/pathogens10030382.

本文引用的文献

1
The coccoid forms of Helicobacter pylori. Criteria for their viability.幽门螺杆菌的球形形态。其生存能力的标准。
Epidemiol Infect. 1993 Dec;111(3):483-90. doi: 10.1017/s0950268800057216.
2
Survival of Helicobacter pylori in water and saline.幽门螺杆菌在水和盐溶液中的存活情况。
J Clin Pathol. 1990 Jul;43(7):609. doi: 10.1136/jcp.43.7.609-b.
3
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.兰索拉唑是一种新型苯并咪唑质子泵抑制剂,其相关化合物对幽门螺杆菌具有选择性活性。
Antimicrob Agents Chemother. 1991 Mar;35(3):490-6. doi: 10.1128/AAC.35.3.490.
4
Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms.幽门螺杆菌从杆菌形态向球菌形态转变的特征描述。
Scand J Gastroenterol Suppl. 1991;181:58-64.
5
[Polymorphism in Helicobacter pylori--a key function in recurrence of infection?].
Med Klin (Munich). 1992 Apr 15;87(4):179-84.